| scholarly article | Q13442814 |
| P50 | author | Richard Dart | Q90953391 |
| P2093 | author name string | Alvaro Muñoz | |
| George E Woody | |||
| James A Inciardi | |||
| Theodore J Cicero | |||
| Sidney Schnoll | |||
| P433 | issue | 2 | |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 157-170 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Pain Medicine | Q15746562 |
| P1476 | title | The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). | |
| P478 | volume | 8 |
| Q37394343 | Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure |
| Q34051864 | Advancing the field of pharmaceutical risk minimization through application of implementation science best practices |
| Q24647780 | Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys |
| Q35548503 | Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. |
| Q38707436 | Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program |
| Q37067411 | Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. |
| Q37479288 | Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System |
| Q33767175 | Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations |
| Q48026600 | Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter". |
| Q92354622 | Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study |
| Q30881147 | Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States |
| Q35183653 | Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007. |
| Q51265568 | Detection of signals of abuse and dependence applying disproportionality analysis. |
| Q34166414 | Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals |
| Q40414322 | Drug availability adjustments in population-based studies of prescription opioid abuse |
| Q37616576 | ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes |
| Q44046695 | Epidemiological trends in abuse and misuse of prescription opioids |
| Q40694899 | Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area |
| Q44335175 | General practitioners' and hospital physicians' preference for morphine or oxycodone as first-time choice for a strong opioid: a National Register-based study |
| Q37915516 | Intentional Coricidin product exposures among Illinois adolescents |
| Q35278475 | Measures to quantify the abuse of prescription opioids: a review of data sources and metrics |
| Q36921364 | Mental health and emergency medicine: a research agenda |
| Q34273774 | Misuse of medicines in the European Union: a systematic review of the literature |
| Q37862258 | Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing |
| Q44335315 | National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse |
| Q52687787 | Near-Real-Time Surveillance of Illnesses Related to Shellfish Consumption in British Columbia: Analysis of Poison Center Data. |
| Q36693189 | Nonmedical use of prescription opioids: motive and ubiquity issues |
| Q28661407 | PREDOSE: a semantic web platform for drug abuse epidemiology using social media |
| Q90378740 | Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis |
| Q35552548 | Patterns of prescription opioid abuse and comorbidity in an aging treatment population |
| Q55362163 | Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors. |
| Q35624464 | Postmarketing surveillance for "modified-risk" tobacco products |
| Q52316624 | Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies. |
| Q39135194 | Prescription drug diversion among substance-impaired pharmacists |
| Q36457495 | Prescription drugs purchased through the internet: who are the end users? |
| Q36851545 | Prescription history of emergency department patients prescribed opioids |
| Q37286475 | Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment |
| Q34223553 | Prescription opioid abuse, pain and addiction: clinical issues and implications |
| Q37496189 | Psychiatric issues in chronic pain |
| Q37131146 | Recovering substance-impaired pharmacists' views regarding occupational risks for addiction |
| Q42221754 | Reductions in prescription opioid diversion following recent legislative interventions in Florida |
| Q44339897 | Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers |
| Q34981568 | Role of key informants and direct patient interviews in epidemiological studies of substance abuse |
| Q37394355 | Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats |
| Q35856578 | Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths |
| Q37048049 | Spatial-temporal disease mapping of illicit drug abuse or dependence in the presence of misaligned ZIP codes |
| Q93016023 | Strengths and weaknesses of existing data sources to support research to address the opioids crisis |
| Q36778736 | Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States. |
| Q53449722 | The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain. |
| Q36638633 | The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability |
| Q31158757 | Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. |
| Q28481410 | Using poison center exposure calls to predict methadone poisoning deaths |
| Q42244056 | Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits |
| Q44335967 | Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse |
| Q45871173 | Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières |
Search more.